SeraCare Life Sciences Expands Gaithersburg, Maryland, Operations Center
06/22/2015
According to company officials, “with strategic investments to expand laboratory and manufacturing space, this new Molecular Diagnostics Center of Excellence for product development and manufacturing will now also provide digital PCR, Next Generation Sequencing technologies and bioinformatics resources to help accelerate the company's goal of enabling precision medicine."
"SeraCare is fully committed to enabling precision medicine through the development of innovative technologies and tools. These new investments in both infrastructure and top notch talent at our Gaithersburg R&D facility are key in allowing us to develop ground-breaking solutions to support the safe and effective expansion of precision-driven diagnostics," says Charlie Mamrak, CEO, SeraCare Life Sciences.
Most Read
-
-
Supply Chain Bottlenecks Creating New “Logistical Hotspots”
Q3 2021
-
2020 Top States for Doing Business Showcase Their Pro-Business Environments
Q3 2020
-
2021 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
Q2 2021
-
35th Annual Corporate Survey: Effects of Global Pandemic Reflected in Executives’ Site and Facility Plans
Q1 2021
-
Latest Trends in the Industrial Real Estate Sector Here to Stay
Q2 2021
-
Auto Industry Is Betting on Sustainability
2021 Auto/Aero Site Guide